Our January 2024 month-in-review spotlights some of our top coverage in nephrology, ranging from FDA news to clinical trial data and research about approaches to improving renal health.
We sat down with Katja Gist, DO, for further insight into the use of continuous renal replacement therapy in children and young adults, spotlighting the importance of timing to therapy initiation.
Each 1-day delay in continuous renal replacement therapy initiation was associated with 3% greater odds of major adverse kidney events at 90 days, including mortality, dialysis dependence, and persistent kidney dysfunction.